Literature DB >> 31833032

Frequency of dendritic cell subsets and ILT3, ILT4 gene expression in two different immunosuppressive protocols in kidney transplant recipients. A cohort report.

Mozhdeh Karimi1,2, Pedram Ahmadpoor3, Mohsen Nafar3, Fatemeh Pourrezagholi3, Saeideh Jamali2, Atefeh Eteghadi2, Mir Saeed Yekaninejad4, Ali Akbar Amirzargar5,6.   

Abstract

Dendritic cells (DCs) have a major role in the initiation of an immune response and Immunoglobulin-like transcript 3&4 (ILT3&ILT4) are inhibitory receptors that induce tolerance in DCs. Recent studies show that immunosuppressive agents affect frequency of DCs. Herein, we compared the effect of mycophenolate mofetil (MMF) and sirolimus (SRL) in tacrolimus (TAC)-based immunosuppression on DC subsets frequency and ILT3/ILT4 gene expression in kidney transplant recipients. We enrolled 24 adult transplant recipients who received MMF/TAC (n = 14) or SRL/TAC (n = 10). Peripheral blood samples were obtained from recipients, 24-48 h before transplantation and 4 months after transplantation. The frequency of DC subsets was analyzed by flow cytometry and gene expression of ILT3/ILT4 were estimated by real-time PCR. Our results showed that MMF vs. SRL treated recipient showed an increase in pDC % with increased in the expression of ILT3/ILT4 which is in favor of better allograft survival; However, for confirming the results of this preliminary study, a cohort study with larger sample size is necessary.

Entities:  

Keywords:  Dendritic cells; ILT3; ILT4; Immunoglobulin-like transcript; Kidney transplantation; Micofenolat mofetil; Sirolimus; Tacrolimus

Mesh:

Substances:

Year:  2019        PMID: 31833032     DOI: 10.1007/s11033-019-05113-x

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  19 in total

1.  BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood.

Authors:  A Dzionek; A Fuchs; P Schmidt; S Cremer; M Zysk; S Miltenyi; D W Buck; J Schmitz
Journal:  J Immunol       Date:  2000-12-01       Impact factor: 5.422

2.  Long-term renal allograft survival: have we made significant progress or is it time to rethink our analytic and therapeutic strategies?

Authors:  Herwig-Ulf Meier-Kriesche; Jesse D Schold; Bruce Kaplan
Journal:  Am J Transplant       Date:  2004-08       Impact factor: 8.086

3.  Analyzing real-time PCR data by the comparative C(T) method.

Authors:  Thomas D Schmittgen; Kenneth J Livak
Journal:  Nat Protoc       Date:  2008       Impact factor: 13.491

4.  Rapamycin induces ILT3(high)ILT4(high) dendritic cells promoting a new immunoregulatory pathway.

Authors:  Giovanni Stallone; Paola Pontrelli; Barbara Infante; Margherita Gigante; Giuseppe S Netti; Elena Ranieri; Giuseppe Grandaliano; Loreto Gesualdo
Journal:  Kidney Int       Date:  2013-10-09       Impact factor: 10.612

5.  A window into immunosuppressant immunoregulation: recipient conversion to rapamycin increases potentially tolerogenic immune cells.

Authors:  Brian R Rosborough; Holger Hackstein; Hēth R Turnquist
Journal:  Kidney Int       Date:  2014-04       Impact factor: 10.612

6.  A prospective, randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation: results at 1 year.

Authors:  Robert Mendez; Thomas Gonwa; Harold C Yang; Samuel Weinstein; Stephen Jensik; Steven Steinberg
Journal:  Transplantation       Date:  2005-08-15       Impact factor: 4.939

7.  Sirolimus in combination with tacrolimus is associated with worse renal allograft survival compared to mycophenolate mofetil combined with tacrolimus.

Authors:  Herwig-Ulf Meier-Kriesche; Jesse D Schold; Titte R Srinivas; Richard J Howard; Shiro Fujita; Bruce Kaplan
Journal:  Am J Transplant       Date:  2005-09       Impact factor: 8.086

8.  Elevated myeloid: plasmacytoid dendritic cell ratio associates with late, but not early, liver rejection in children induced with rabbit anti-human thymocyte globulin.

Authors:  Ankit Gupta; Chethan Ashok Kumar; Mylarappa Ningappa; Qing Sun; Brandon W Higgs; Sara Snyder; Adriana Zeevi; Angus W Thomson; George V Mazariegos; Rakesh Sindhi
Journal:  Transplantation       Date:  2009-08-27       Impact factor: 4.939

9.  Rapamycin downregulates the inhibitory receptors ILT2, ILT3, ILT4 on human dendritic cells and yet induces T cell hyporesponsiveness independent of FoxP3 induction.

Authors:  Boris Fedoric; Ravi Krishnan
Journal:  Immunol Lett       Date:  2008-07-22       Impact factor: 3.685

10.  Plasmacytoid dendritic cells induce tolerance predominantly by cargoing antigen to lymph nodes.

Authors:  Karan Kohli; Anika Janssen; Reinhold Förster
Journal:  Eur J Immunol       Date:  2016-10-18       Impact factor: 5.532

View more
  2 in total

Review 1.  Leukocyte immunoglobulin-like receptor subfamily B: therapeutic targets in cancer.

Authors:  Mi Deng; Heyu Chen; Xiaoye Liu; Ryan Huang; Yubo He; Byounggyu Yoo; Jingjing Xie; Samuel John; Ningyan Zhang; Zhiqiang An; Cheng Cheng Zhang
Journal:  Antib Ther       Date:  2021-02-09

2.  Evaluation of Thymic Output and Regulatory T Cells in Kidney Transplant Recipients with Chronic Antibody-Mediated Rejection.

Authors:  Abbas Shahi; Saeedeh Salehi; Shima Afzali; Ladan Gol Mohammad Pour Afrakoti; Marzie Esmaeili; Farzaneh Bagherpour; Ziba Aghsaeifard; Sanaz Dehghani; Gholamreza Pourmand; Ali Akbar Amirzargar
Journal:  Biomed Res Int       Date:  2021-02-09       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.